Literature DB >> 33177933

Simultaneous Determination of Hydrochlorothiazide and Irbesartan from Pharmaceutical Dosage Forms with RP-HPLC.

Sevinç KurbanoĞlu1, Aysu Yarman2.   

Abstract

OBJECTIVES: In this work, a simple and rapid liquid chromatographic method for the simultaneous determination of irbesartan (IRBE) and hydrochlorothiazide (HCT) was developed and validated by reverse phase high performance liquid chromatography (RP-HPLC).
MATERIALS AND METHODS: Experimental conditions such as different buffer solutions, various pH values, temperature, composition of the mobile phase, and the effect of flow rate were optimized.
RESULTS: The developed RP-HPLC method for these antihypertensive agents was wholly validated and IRBE was detected in the linear range of 0.1-25 μg mL-1 and HCT was detected in the linear range of 0.25-25 μg mL-1. Moreover, the suggested chromatographic technique was successfully applied for the determination of the drugs in human serum and pharmaceutical dosage forms with limit of detection values of 0.008 μg mL-1 for IRBE and 0.012 μg mL-1 for HCT.
CONCLUSION: The proposed rapid analysis method of these antihypertensive drugs can be easily used and applied by pharmaceutical companies for which the analysis time is important. ©Copyright 2020 Turk J Pharm Sci, Published by Galenos Publishing House.

Entities:  

Keywords:  HPLC; hydrochlorothiazide; irbesartan; pharmaceutical dosage forms

Year:  2020        PMID: 33177933      PMCID: PMC7650730          DOI: 10.4274/tjps.galenos.2019.76094

Source DB:  PubMed          Journal:  Turk J Pharm Sci        ISSN: 1304-530X


  13 in total

1.  Simultaneous determination of hydrochlorothiazide and several angiotensin-II-receptor antagonists by capillary electrophoresis.

Authors:  S Hillaert; W Van den Bossche
Journal:  J Pharm Biomed Anal       Date:  2003-02-26       Impact factor: 3.935

2.  The clinical pharmacology of hydrochlorothiazide.

Authors:  R V FORD
Journal:  South Med J       Date:  1959-01       Impact factor: 0.954

Review 3.  Irbesartan: review of pharmacology and comparative properties.

Authors:  M A Adams; L Trudeau
Journal:  Can J Clin Pharmacol       Date:  2000

4.  The effects of age and gender on the pharmacokinetics of irbesartan.

Authors:  N N Vachharajani; W C Shyu; R A Smith; D S Greene
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 5.  Clinical epidemiology of cardiovascular disease in chronic renal disease.

Authors:  R N Foley; P S Parfrey; M J Sarnak
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

6.  Hypertension management: an update.

Authors:  Quang Nguyen; Joann Dominguez; Loida Nguyen; Nageshwara Gullapalli
Journal:  Am Health Drug Benefits       Date:  2010-01

7.  Simultaneous estimation and validation of some binary mixtures of antihypertensive drugs by RP-LC methods using two new generation silica columns.

Authors:  Sevinc Kurbanoglu; Mehmet Gumustas; Sibel A Ozkan
Journal:  J Pharm Biomed Anal       Date:  2012-08-27       Impact factor: 3.935

8.  Determination of irbesartan in the presence of hydrochlorothiazide by derivative spectrophotometry.

Authors:  Isabel Albero; Vicente Ródenas; Soledad García; Concepción Sánchez-Pedreño
Journal:  J Pharm Biomed Anal       Date:  2002-06-20       Impact factor: 3.935

9.  Spectrofluorimetric method for determination of some angiotensin II receptor antagonists.

Authors:  Salwa R El-Shaboury; Samiha A Hussein; Niveen A Mohamed; Mohamed M El-Sutohy
Journal:  J Pharm Anal       Date:  2011-11-10

10.  Simultaneous analysis of irbesartan and hydrochlorothiazide: an improved HPLC method with the aid of a chemometric protocol.

Authors:  Zorica Vujić; Nedžad Mulavdić; Miralem Smajić; Jasmina Brborić; Predrag Stankovic
Journal:  Molecules       Date:  2012-03-16       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.